当前位置: X-MOL 学术Crit. Rev. Ther. Drug Carr. Syst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Insights into the Approach, Fabrication, Application, and Lacunae of Nanoemulsions in Drug Delivery Systems
Critical Reviews in Therapeutic Drug Carrier Systems ( IF 2.7 ) Pub Date : 2020-01-01 , DOI: 10.1615/critrevtherdrugcarriersyst.2020030291
Kumar Anand 1 , Mahfoozur Rahman 2 , Subhabrata Ray 3 , Sanmoy Karmakar 1
Affiliation  

Many of the recently approved drug molecules that are therapeutically successful are found to be incompatible for the development of a novel delivery system and to take part in various health care management. Regardless of having better therapeutic properties, these molecules are barred from their effective clinical uses. The main reason attributed to it is poor solubility and/or poor permeability of drugs which finally emerges the drug to be low bioavailable. Nanoemulsions are one of the most acceptable nanolipoidal drug delivery system and appears to be a hope for the delivery of many of the Biopharmaceutical Classification System (BCS) class II and IV drugs. A nanoemulsion is a thermodynamically unstable isotropic mixture of oil, surfactant, and co-surfactants and is biphasic in nature. It can be either water in oil or oil in water and droplets are found in the range of 5 to 500 nm. The manufacturing and fabrication of nanoemulsions involve various natural, synthetic and semi synthetic materials using either low or high-energy methods. Application of nanoemulsions as a novel drug delivery system through several routes, especially oral, transdermal, ophthalmic, and intranasal, have been increased for various pharmacological aspects such as cardiovascular, anticancer, antimicrobial, and ophthalmic due to their stability, high solubilization capacity, and ease of preparation. The objective of this review is to focus on the aspects of manufacturing, fabrication, application, and some toxicological concerns related to nanoemulsions.

中文翻译:

对药物输送系统中纳米乳剂的方法,制造,应用和缺陷的见解

发现在治疗上成功的许多最近批准的药物分子与新型递送系统的开发不相容,并且不能参与各种医疗保健管理。不管具有更好的治疗特性,这些分子都被禁止用于其有效的临床用途。归因于其的主要原因是药物的溶解性差和/或渗透性差,这最终使药物的生物利用度降低。纳米乳剂是最可接受的纳米脂质体药物递送系统之一,并且似乎是许多生物制药分类系统(BCS)II类和IV类药物递送的希望。纳米乳液是油,表面活性剂和助表面活性剂的热力学不稳定的各向同性混合物,本质上是两相的。它可以是油中的水或油中的油,并且发现的液滴范围为5至500 nm。纳米乳液的制造和制造涉及使用低能或高能方法的各种天然,合成和半合成材料。由于其稳定性,高溶解能力和稳定性,通过多种途径,尤其是通过口服,透皮,眼科和鼻内途径,将纳米乳剂作为新型药物输送系统,已用于心血管,抗癌,抗微生物和眼科等各种药理学领域。易于准备。这篇综述的目的是集中在制造,制造,应用以及与纳米乳液有关的一些毒理学方面。纳米乳液的制造和制造涉及使用低能或高能方法的各种天然,合成和半合成材料。由于其稳定性,高溶解能力和稳定性,通过多种途径,尤其是通过口服,透皮,眼科和鼻内途径,将纳米乳剂作为新型药物输送系统,已用于心血管,抗癌,抗微生物和眼科等各种药理学领域。易于准备。这篇综述的目的是集中在制造,制造,应用以及与纳米乳液有关的一些毒理学方面。纳米乳液的制造和制造涉及使用低能或高能方法的各种天然,合成和半合成材料。由于其稳定性,高溶解能力和稳定性,通过多种途径,尤其是通过口服,透皮,眼科和鼻内途径,将纳米乳剂作为新型药物输送系统,已用于心血管,抗癌,抗微生物和眼科等各种药理学领域。易于准备。这篇综述的目的是集中在制造,制造,应用以及与纳米乳液有关的一些毒理学方面。由于它们的稳定性,高溶解能力和易于制备,经皮,眼科和鼻内用药已被用于各种药理学方面,例如心血管,抗癌,抗微生物和眼科。这篇综述的目的是集中在制造,制造,应用以及与纳米乳液有关的一些毒理学方面。由于它们的稳定性,高溶解能力和易于制备,经皮,眼科和鼻内用药已被用于各种药理学方面,例如心血管,抗癌,抗微生物和眼科。这篇综述的目的是集中在制造,制造,应用以及与纳米乳液有关的一些毒理学方面。
更新日期:2020-01-01
down
wechat
bug